503 filings
Page 4 of 26
8-K
g5450a g8mzn
19 Apr 23
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
8:07am
8-K
nsw4bf7
18 Apr 23
OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel
4:45pm
UPLOAD
0am 1vjx52csxr
13 Apr 23
Letter from SEC
12:00am
8-K
6ck16577d7982cg8k
30 Mar 23
OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
5:11pm
8-K
wwtde
14 Mar 23
Changes in Registrant's Certifying Accountant
12:48pm
8-K
nzz zmhbm2my
17 Feb 23
OpGen Announces Exercise of All Prefunded Warrants
8:55am
8-K
cvlq26
23 Jan 23
Other Events
8:00am
8-K
po81mpl
20 Jan 23
Changes in Registrant's Certifying Accountant
4:32pm
8-K
hmwlhjnpvw5rz
18 Jan 23
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
4:36pm
8-K
4yjslph
11 Jan 23
OpGen Announces Pricing of $7.5 Million Public Offering
4:37pm
424B3
gx517
11 Jan 23
Prospectus supplement
7:03am
EFFECT
wfpixl7lgc56f21
9 Jan 23
Notice of effectiveness
12:15am
CORRESP
cfz1ph8gz 1ffqkeaey6
5 Jan 23
Correspondence with SEC
12:00am
CORRESP
5hiddunuqm3aq0l23
5 Jan 23
Correspondence with SEC
12:00am
8-K
yp45pgtqs 1h
4 Jan 23
OpGen Announced 1-for-20 Reverse Stock Split
4:48pm
CORRESP
hhnycvekrelh
30 Dec 22
Correspondence with SEC
12:00am